CN102351783B - The synthetic method of 1-benzyl-3-piperidone hydrochloride - Google Patents
The synthetic method of 1-benzyl-3-piperidone hydrochloride Download PDFInfo
- Publication number
- CN102351783B CN102351783B CN201110242392.9A CN201110242392A CN102351783B CN 102351783 B CN102351783 B CN 102351783B CN 201110242392 A CN201110242392 A CN 201110242392A CN 102351783 B CN102351783 B CN 102351783B
- Authority
- CN
- China
- Prior art keywords
- product
- benzyl
- reaction
- add
- hour
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- OVWSFXNSJDMRPV-UHFFFAOYSA-N 1-benzylpiperidin-3-one;hydron;chloride Chemical compound Cl.C1C(=O)CCCN1CC1=CC=CC=C1 OVWSFXNSJDMRPV-UHFFFAOYSA-N 0.000 title claims abstract description 33
- 238000010189 synthetic method Methods 0.000 title claims abstract description 23
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims abstract description 138
- 238000006243 chemical reaction Methods 0.000 claims abstract description 70
- 239000000243 solution Substances 0.000 claims abstract description 56
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 40
- 239000012074 organic phase Substances 0.000 claims abstract description 29
- 238000003756 stirring Methods 0.000 claims abstract description 24
- 238000000605 extraction Methods 0.000 claims abstract description 20
- 238000001816 cooling Methods 0.000 claims abstract description 13
- 239000003960 organic solvent Substances 0.000 claims abstract description 13
- 239000007787 solid Substances 0.000 claims abstract description 13
- 238000005406 washing Methods 0.000 claims abstract description 12
- 239000008346 aqueous phase Substances 0.000 claims abstract description 11
- 229910000033 sodium borohydride Inorganic materials 0.000 claims abstract description 11
- 239000012279 sodium borohydride Substances 0.000 claims abstract description 11
- GRFNBEZIAWKNCO-UHFFFAOYSA-N 3-pyridinol Chemical compound OC1=CC=CN=C1 GRFNBEZIAWKNCO-UHFFFAOYSA-N 0.000 claims abstract description 9
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims abstract description 9
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 9
- 230000026030 halogenation Effects 0.000 claims abstract description 9
- 238000005658 halogenation reaction Methods 0.000 claims abstract description 9
- 239000002253 acid Substances 0.000 claims abstract description 5
- 239000012670 alkaline solution Substances 0.000 claims abstract description 5
- 241001122315 Polites Species 0.000 claims abstract description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 3
- 125000000468 ketone group Chemical group 0.000 claims abstract description 3
- 230000001590 oxidative effect Effects 0.000 claims abstract description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 100
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 78
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 claims description 48
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 45
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 30
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 24
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 24
- 239000000126 substance Substances 0.000 claims description 17
- 238000001035 drying Methods 0.000 claims description 16
- 239000002994 raw material Substances 0.000 claims description 16
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 14
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
- 238000010992 reflux Methods 0.000 claims description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 9
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 claims description 9
- 229940073608 benzyl chloride Drugs 0.000 claims description 9
- 230000004044 response Effects 0.000 claims description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 8
- 239000007864 aqueous solution Substances 0.000 claims description 8
- 238000010438 heat treatment Methods 0.000 claims description 8
- 239000012535 impurity Substances 0.000 claims description 8
- 229920006395 saturated elastomer Polymers 0.000 claims description 8
- 238000000967 suction filtration Methods 0.000 claims description 8
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 6
- PXOIIZOTNBIMPZ-UHFFFAOYSA-N dichloromethane;oxalyl dichloride Chemical compound ClCCl.ClC(=O)C(Cl)=O PXOIIZOTNBIMPZ-UHFFFAOYSA-N 0.000 claims description 4
- 230000002829 reductive effect Effects 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims 1
- 239000012141 concentrate Substances 0.000 description 12
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- 239000007789 gas Substances 0.000 description 7
- 206010013786 Dry skin Diseases 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 5
- GKECDORWWXXNRY-UHFFFAOYSA-N 2h-pyridin-3-one Chemical class O=C1CN=CC=C1 GKECDORWWXXNRY-UHFFFAOYSA-N 0.000 description 4
- 239000003054 catalyst Substances 0.000 description 4
- 229910000510 noble metal Inorganic materials 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- UTTCOAGPVHRUFO-UHFFFAOYSA-N 1-benzylpiperidin-3-ol Chemical compound C1C(O)CCCN1CC1=CC=CC=C1 UTTCOAGPVHRUFO-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- DSVGQVZAZSZEEX-UHFFFAOYSA-N [C].[Pt] Chemical compound [C].[Pt] DSVGQVZAZSZEEX-UHFFFAOYSA-N 0.000 description 1
- YKIOKAURTKXMSB-UHFFFAOYSA-N adams's catalyst Chemical compound O=[Pt]=O YKIOKAURTKXMSB-UHFFFAOYSA-N 0.000 description 1
- 238000007098 aminolysis reaction Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- PQJJJMRNHATNKG-UHFFFAOYSA-N ethyl bromoacetate Chemical compound CCOC(=O)CBr PQJJJMRNHATNKG-UHFFFAOYSA-N 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-N hydroperoxyl Chemical compound O[O] OUUQCZGPVNCOIJ-UHFFFAOYSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- RPNNPZHFJPXFQS-UHFFFAOYSA-N methane;rhodium Chemical compound C.[Rh] RPNNPZHFJPXFQS-UHFFFAOYSA-N 0.000 description 1
- BIWOSRSKDCZIFM-UHFFFAOYSA-N piperidin-3-ol Chemical compound OC1CCCNC1 BIWOSRSKDCZIFM-UHFFFAOYSA-N 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
Landscapes
- Hydrogenated Pyridines (AREA)
Abstract
Description
Claims (10)
- The synthetic method of 1.1-benzyl-3-piperidone hydrochloride, is characterized in that, comprise the steps:(1) raw material 3-pyridone is added in organic solvent, under 100-110 DEG C of reflux state, drips halogenation benzyl, continue back flow reaction 2-4 hour, obtain product A, described organic solvent be selected from toluene, ethyl acetate, methylene dichloride one or more;(2) product A is added in alcohol organic solvent, under ice bath, after adding sodium borohydride, recover room temperature stirring reaction 10-15 hour, then add shrend and to go out reaction solution, remove alcohol organic solvent, adding strong acid adjusts pH to be 1-2, extraction agent extraction retains aqueous phase, with alkaline solution adjust pH to 13-14, obtains product B;(3) mix with dimethyl sulfoxide (DMSO) after oxalyl chloride being dissolved with methylene dichloride, in mixing solutions, add the product B of dissolving with methylene dichloride, then add the triethylamine dissolved with methylene dichloride, polite oxidizing reaction occurring by the hydroxyl oxidize in product B is ketone group, washing, dry organic phase, filter, concentrated, add hydrochloric ethyl acetate solution until pH is 1-2, stir, cooling, after solid is separated out completely, filter, dry to obtain described 1-benzyl-3-piperidone hydrochloride.
- 2. synthetic method according to claim 1, it is characterized in that: described step (3) is for dissolve oxalyl chloride methylene dichloride, be cooled to-78-(-75) DEG C, dimethyl sulfoxide (DMSO) is dripped to it, the product B that step (2) is obtained is dissolved in methylene dichloride, slowly be added drop-wise to and be above-mentionedly mixed with in the solution of oxalyl chloride and dimethyl sulfoxide (DMSO), remain temperature-78-(-75) DEG C, dropwise rear reaction 0.5-1 hour, the triethylamine dissolved with methylene dichloride is added drop-wise in reaction solution, keep temperature-78-(-75) DEG C, dropwise reaction 0.5-1 hour, return to room temperature and place 10-15 hour, react completely, washing, dry organic phase, filter, concentrated, add hydrochloric ethyl acetate solution until pH is 1-2, stir, cooling, after solid is separated out completely, filter, dry to obtain described 1-benzyl-3-piperidone hydrochloride.
- 3. synthetic method according to claim 1, is characterized in that: in step (1), and described halogenation benzyl is Benzyl Chloride or cylite.
- 4. synthetic method according to claim 1, is characterized in that: in described step (1), and raw material is 1:1-1.5 with the ratio of the amount of substance of halogenation benzyl.
- 5. synthetic method according to claim 1, it is characterized in that: in described step (2), strong acid is one or more in concentrated hydrochloric acid, sulfuric acid, acetic acid, and alcohol organic solvent is selected from methyl alcohol or ethanol, extraction agent be selected from ethyl acetate, methylene dichloride, chloroform one or more.
- 6. synthetic method according to claim 1, is characterized in that: in described step (2), and product A is 1:2-3 with the ratio of the amount of substance of reductive agent.
- 7. synthetic method according to claim 1, is characterized in that: in described step (2), the sodium hydroxide solution of alkaline solution to be mass percent be 10%-15%.
- 8. synthetic method according to claim 1 and 2, it is characterized in that: in described step (3), product B is 1:1-1.2 with the amount of substance ratio of oxalyl chloride, and oxalyl chloride and dimethyl sulfoxide (DMSO) amount of substance are than being 1:2, and product B and triethylamine amount of substance are than being 1:4-5.
- 9. synthetic method according to claim 1 and 2, is characterized in that: in step (3), and described hydrochloric ethyl acetate solution is by being passed in ethyl acetate by HCl gas, until saturated obtained.
- 10. the synthetic method according to any one of claim 1-7, is characterized in that, comprises the steps:(1) take raw material 3-pyridone, add toluene, heating for dissolving, under 105 DEG C of reflux states, drip Benzyl Chloride, add in 30 minutes, continue back flow reaction 2 hours, react completely, question response drops to room temperature, suction filtration, dries to obtain product A; Wherein, raw material is 1:1.1 with the ratio of the amount of substance of halogenation benzyl;(2) product A is added in ethanol, under ice bath, slowly add sodium borohydride in batches, after adding, recover room temperature stirring reaction 10-15 hour, react completely, add shrend to go out reaction solution, spin off ethanol, add concentrated hydrochloric acid and adjust pH to be 1-2, be extracted with ethyl acetate impurity, aqueous phase, is extracted with ethyl acetate to 13-14 with 10% sodium hydroxide adjust pH, saturated nacl aqueous solution washes organic phase once, by anhydrous sodium sulfate drying organic phase 2 hours, filter, concentratedly to obtain product B; Wherein, product A is 1:2 with the ratio of the amount of substance of reductive agent;(3) oxalyl chloride methylene dichloride is dissolved, be cooled to-78 DEG C, drip dimethyl sulfoxide (DMSO), product B is dissolved in methylene dichloride, slowly be added drop-wise to and be above-mentionedly mixed with in the solution of oxalyl chloride and dimethyl sulfoxide (DMSO), temperature remains at-78 DEG C, dropwise rear reaction 0.5 hour, the triethylamine dissolved with methylene dichloride is added drop-wise in reaction solution, temperature keeps-78 DEG C, dropwise reaction 0.5 hour, return to room temperature and place 10-15 hour, react completely, washing, organic phase anhydrous sodium sulfate drying, filter, concentrated, add hydrochloric ethyl acetate solution until pH is 1-2, stir, cooling, after solid is separated out completely, filter, dry to obtain described 1-benzyl-3-piperidone hydrochloride, wherein, product B is 1:1.1 with the amount of substance ratio of oxalyl chloride, and oxalyl chloride and dimethyl sulfoxide (DMSO) amount of substance are than being 1:2, and product B and triethylamine amount of substance are than being 1:4.6.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110242392.9A CN102351783B (en) | 2011-08-23 | 2011-08-23 | The synthetic method of 1-benzyl-3-piperidone hydrochloride |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110242392.9A CN102351783B (en) | 2011-08-23 | 2011-08-23 | The synthetic method of 1-benzyl-3-piperidone hydrochloride |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102351783A CN102351783A (en) | 2012-02-15 |
CN102351783B true CN102351783B (en) | 2015-11-18 |
Family
ID=45575454
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110242392.9A Expired - Fee Related CN102351783B (en) | 2011-08-23 | 2011-08-23 | The synthetic method of 1-benzyl-3-piperidone hydrochloride |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102351783B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103204801A (en) * | 2013-04-12 | 2013-07-17 | 兰州远辉生物科技有限公司 | Synthesis method for N-Boc-3-piperidone |
CN103304472A (en) * | 2013-06-15 | 2013-09-18 | 扬州天和药业有限公司 | Method for synthesizing 1-BOC-3-piperidone |
CN105693598B (en) * | 2014-11-28 | 2017-12-19 | 中国科学院大连化学物理研究所 | A kind of method that iridium catalytic hydrogenation synthesizes 3 derivative of piperidone |
CN104529872B (en) * | 2014-12-10 | 2018-07-10 | 天津长源医药科技有限公司 | A kind of synthetic method of benidipine hydrochloride intermediate |
CN105949113A (en) * | 2016-05-24 | 2016-09-21 | 苏州艾缇克药物化学有限公司 | Method for efficiently synthesizing 1-Boc-3-piperidone |
CN115073358B (en) * | 2022-07-21 | 2023-09-26 | 安徽德诺医药股份有限公司 | Preparation method of N-benzyl-4-ethyl piperidine formate |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1450993A (en) * | 1999-07-20 | 2003-10-22 | 道农业科学公司 | Fungicidal heterocyclic aromatic amides and their compositions methods of use and preparation |
WO2005026145A2 (en) * | 2003-09-12 | 2005-03-24 | Warner-Lambert Company Llc | Quinolone antibacterial agents |
US20060074087A1 (en) * | 2003-01-31 | 2006-04-06 | Ashton Wallace T | 3-Amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
CN102070514A (en) * | 2011-02-23 | 2011-05-25 | 南通远航医药化工有限公司 | Method for preparing halofuginone intermediate |
CN101759630B (en) * | 2010-01-28 | 2011-12-28 | 浙江大学 | Method for synthesizing N-benzyl-4-methyl-3-piperidone |
-
2011
- 2011-08-23 CN CN201110242392.9A patent/CN102351783B/en not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1450993A (en) * | 1999-07-20 | 2003-10-22 | 道农业科学公司 | Fungicidal heterocyclic aromatic amides and their compositions methods of use and preparation |
US20060074087A1 (en) * | 2003-01-31 | 2006-04-06 | Ashton Wallace T | 3-Amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
WO2005026145A2 (en) * | 2003-09-12 | 2005-03-24 | Warner-Lambert Company Llc | Quinolone antibacterial agents |
CN101759630B (en) * | 2010-01-28 | 2011-12-28 | 浙江大学 | Method for synthesizing N-benzyl-4-methyl-3-piperidone |
CN102070514A (en) * | 2011-02-23 | 2011-05-25 | 南通远航医药化工有限公司 | Method for preparing halofuginone intermediate |
Non-Patent Citations (3)
Title |
---|
.《高等化学工程学报》.2011,第25卷(第6期),第1021-1025页. * |
Iselin, B. M.;Hoffmann, K..Alkylenimine derivatives. Synthesis of 3-aryl-3-hydroxy-piperidines.《Helvetica Chimica Acta》.1954,第37卷第178-84页. * |
郝宝玉等.1-叔丁羰基-4-甲基-3-哌啶酮的合成研究 * |
Also Published As
Publication number | Publication date |
---|---|
CN102351783A (en) | 2012-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102351783B (en) | The synthetic method of 1-benzyl-3-piperidone hydrochloride | |
TW200932749A (en) | Process improvement using TMEDA | |
CN103012551B (en) | Synthetic method of high-purity bortezomib and intermediate thereof | |
CN110204498B (en) | Method for efficiently synthesizing oxagoril intermediate | |
CN105130950A (en) | Bisamide-substituted novel calixcrown ether compound as well as synthesis method and application thereof | |
CN102295638B (en) | Novel method for preparing lapatinib | |
CN112062767B (en) | Preparation method and intermediate of rumepilone | |
CN103073438A (en) | Ambroxol hydrochloride compound refining method | |
CN108467355A (en) | (R) preparation method of-Esomeprazole | |
CN103073519A (en) | Method for preparing dextro-pramipexole hydrochloride | |
AU2017214243A1 (en) | Improved process for the preparation of osimertinib (AZD9291) or a salt thereof, and "AZD9291 aniline" or a salt thereof | |
CN101735023B (en) | Method for preparing 3-bromo-5-chlorophenol | |
CN104860923A (en) | Vonoprazan fumarate preparation method | |
CN102746211B (en) | Method for preparing substituted indole-3-methanal compound | |
CN106866434B (en) | A kind of preparation method of VENLAFAXINE HCL intermediate | |
CN106397227B (en) | A kind of preparation method of Dapoxetine hydrochloride hydrochloride | |
CN106046077A (en) | Tulathromycin A synthesis method | |
CN104193638A (en) | Method for preparing (S)-2',6'-dimethyl tyrosine and derivative of (S)-2',6'-dimethyl tyrosine, and derivative | |
CN106916079A (en) | A kind of synthetic method of the methacetin of the mark of carbon 13 | |
CN112341347B (en) | Synthetic method of ambroxol hydrochloride | |
CN101157591B (en) | Method for nitryl rduction to produce amido in compound containing nitryl phenyl | |
CN104326927B (en) | A kind of preparation method of 1-[2-amino-1-(4-methoxyphenyl) ethyl] Hexalin sulfate | |
CN107382753B (en) | A kind of preparation method of high-purity hydrochloric acid ritodrine | |
CN101759573B (en) | Synthetic method of N-rimantadine | |
CN103896784B (en) | A kind of FTY720 intermediate nitroreduction is amino method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20151023 Address after: Gansu province Lanzhou City Road 730000 Anning District No. 139 jujube Applicant after: Li Jiandong Address before: Gansu province Lanzhou City Road 730070 Anning District No. 139 jujube Applicant before: Lanzhou BOC Chemical Co., Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20161216 Address after: Road 730070 in Gansu province in Anning District of Lanzhou jujube No. 139 (Science Park) Patentee after: Lanzhou Boshi Biochemical Technology Co., Ltd. Address before: Gansu province Lanzhou City Road 730000 Anning District No. 139 jujube Patentee before: Li Jiandong |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20151118 Termination date: 20170823 |